Monograph

V03AC02 - Deferiprone

Propably not porphyrinogenic

Rationale

Non-CYP metabolism.

Chemical description

Bidentate ligand which binds iron. Used for treatment of iron excess in thalassemia, and in cases where deferoxamine has given rise to toxic reactions. Excreted in unchanged form, as glucuronide and as iron-ferioprone complex.

Similar drugs

Explore alternative drugs in similar therapeutic classes V03A / V03AC or go back.

Tradenames and packages

From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Netherlands

Deferiprone · Deferiprone Lipomed 500 mg filmomhulde tabletten · Ferriprox · Ferriprox 100 mg/ml, vloeistof voor oraal gebruik · Ferriprox 1000 mg, filmomhulde tabletten · Ferriprox, 500 mg filmomhulde tabletten

Belgium

Deferiprone · Deferiprone Lipomed 500 mg compr. pellic. · Ferriprox · Ferriprox 1 000 mg compr. pellic. · Ferriprox 100 mg/ml sol. buv. · Ferriprox 500 mg comp.

United Kingdom

Deferiprone · Deferiprone 400mg capsules · Deferiprone 400mg/5ml oral solution · Deferiprone 400mg/5ml oral suspension · Deferiprone 500mg tablets · Ferriprox · Ferriprox 1000mg tablets · Ferriprox 100mg/ml oral solution · Ferriprox 500mg tablets

Denmark